Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

S. R. Lentz, M. Cerqueira, D. Janic, C. Kempton, I. Matytsina, M. Misgav, J. Oldenburg, M. Ozelo, M. Recht, A. Rosholm, A. Savic, T. Suzuki, A. Tiede, E. Santagostino

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A'. Together they form a unique fingerprint.